Status:
RECRUITING
Carotid Endarterectomy vs. Repeated Carotid Angioplasty and Stenting for In-Stent Restenosis
Lead Sponsor:
University Hospital Ostrava
Conditions:
In-Stent Carotid Artery Restenosis
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
Patients with in-stent restenosis in carotid artery indicated to carotid intervention will be randomized into repeated carotid percutaneous transluminal angioplasty with or without stenting or carotid...
Detailed Description
Patients: Patients with in-stent restenosis in carotid artery indicated to carotid intervention will be randomized into repeated carotid percutaneous transluminal angioplasty with or without stenting ...
Eligibility Criteria
Inclusion
- In-stent restenosis in carotid artery 70 - 99 %
- Indication to carotid intervention
- Age 18-80 years
- Functionally independent with a modified Rankin score value of 0 - 2 points
- Signed Informed consent
Exclusion
- Contraindication to general anesthesia
- Contraindication to angiography (iodine allergy, etc.)
- Technically impossible to perform angioplasty with or without stenting
- Participation in other clinical study within 60 days
- Technically impossible to perform carotid endarterectomy
Key Trial Info
Start Date :
May 25 2017
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2027
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT05390983
Start Date
May 25 2017
End Date
December 1 2027
Last Update
January 18 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital Ostrava
Ostrava, Moravskoslezský kraj, Czechia, 70852